| scholarly article | Q13442814 |
| P50 | author | Robert A Bonomo | Q62516257 |
| P2093 | author name string | Jun Yan | |
| Brad Spellberg | |||
| Evgeny Vinogradov | |||
| Thomas Schneider | |||
| Thomas A Russo | |||
| Kevin W Bruhn | |||
| Kristine M Hujer | |||
| Paul Pantapalangkoor | |||
| T Nicholas Domitrovic | |||
| Brian M Luna | |||
| Sarah Hsieh | |||
| Travis B Nielsen | |||
| Ken Dekitani | |||
| Brandon Yeshoua | |||
| Bryan Pascual | |||
| Magda Lesczcyniecka | |||
| P2860 | cites work | Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine | Q82280648 |
| Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea | Q95813959 | ||
| Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection | Q28478751 | ||
| Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models | Q28539933 | ||
| Gene array analysis of adrenal glands in broiler chickens following ACTH treatment | Q33502880 | ||
| Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. | Q33613907 | ||
| Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii | Q33934704 | ||
| Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes | Q34685659 | ||
| Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia | Q35661920 | ||
| Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies | Q35829780 | ||
| Global challenge of multidrug-resistant Acinetobacter baumannii | Q36095081 | ||
| Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis | Q36457770 | ||
| Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes | Q36569183 | ||
| The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. | Q36646787 | ||
| The capsular polysaccharide and lipopolysaccharide structures of two carbapenem resistant Klebsiella pneumoniae outbreak isolates. | Q36674044 | ||
| White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens | Q36854025 | ||
| The FDA reboot of antibiotic development | Q37263756 | ||
| A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline | Q37374012 | ||
| Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. | Q37780543 | ||
| A multifunctional bispecific antibody protects against Pseudomonas aeruginosa | Q38940907 | ||
| Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges | Q39038590 | ||
| The value of single-pathogen antibacterial agents. | Q39309271 | ||
| Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin | Q39373932 | ||
| Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells | Q40399176 | ||
| The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America | Q41445493 | ||
| Extensively drug-resistant Acinetobacter baumannii | Q43069244 | ||
| Global spread of carbapenem-resistant Acinetobacter baumannii | Q43227337 | ||
| Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia | Q43284715 | ||
| The structure of the polysaccharide isolated from Acinetobacter baumannii strain LAC-4. | Q43463983 | ||
| K19 capsular polysaccharide of Acinetobacter baumannii is produced via a Wzy polymerase encoded in a small genomic island rather than the KL19 capsule gene cluster. | Q53078312 | ||
| Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii | Q58815430 | ||
| The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation | Q80757080 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | 489-501 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis | |
| P478 | volume | 216 |
| Q91908687 | A current appraisal of evidence for the approach to sepsis and septic shock |
| Q96230670 | A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii |
| Q91720902 | Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci |
| Q91859062 | Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against Neisseria gonorrhoeae |
| Q90236842 | Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia |
| Q53703028 | Narrow-Spectrum Antibacterial Agents. |
| Q91989820 | Natural history of Acinetobacter baumannii infection in mice |
| Q58597464 | Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea |
| Q57461276 | New Treatment Options Against Carbapenem-Resistant Infections |
| Q52609091 | Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection. |
Search more.